Novavax Stock Price on November 14, 2023
| NVAX Stock | USD 6.97 0.12 1.69% |
Below is the normalized historical share price chart for Novavax extending back to December 05, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novavax stands at 6.97, as last reported on the 3rd of October, with the highest price reaching 6.97 and the lowest price hitting 6.97 during the day.
If you're considering investing in Novavax Stock, it is important to understand the factors that can impact its stock price. We consider Novavax slightly risky. Novavax has Sharpe Ratio of 0.0161, which conveys that the firm had 0.0161% of return per unit of risk over the last 3 months. Our standpoint towards estimating the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Novavax, which you can use to evaluate the future volatility of the firm. Please verify Novavax Risk Adjusted Performance of 0.0168, downside deviation of 4.46, and Mean Deviation of 4.25 to check out if the risk estimate we provide is consistent with the expected return of 0.1%.
Net Income Common Stock is likely to drop to about (675.3 M) in 2023. Price to Sales Ratio is likely to rise to 0.42 in 2023, whereas Price to Book Value is likely to drop (1.38) in 2023. Novavax Stock stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of December 1995 | 200 Day MA 8.5362 | 50 Day MA 7.9136 | Beta 1.6826 |
Novavax |
Sharpe Ratio = 0.0161
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | NVAX | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.38 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Novavax is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novavax by adding it to a well-diversified portfolio.
Price Book 49.522 | Enterprise Value Ebitda (0.41) | Price Sales 0.4812 | Shares Float 82 M | Wall Street Target Price 20.6 |
Novavax Valuation on November 14, 2023
It is possible to determine the worth of Novavax on a given historical date. On November 14, 2023 Novavax was worth 7.09 at the beginning of the trading date compared to the closed value of 6.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novavax stock. Still, in general, we apply an absolute valuation method to find Novavax's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novavax where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novavax's related companies.
| Open | High | Low | Close | Volume | |
| 7.24 | 7.31 | 7.04 | 7.09 | 5,100,958 | |
10/03/2023 | 7.09 | 6.97 | 6.97 | 6.97 | 0.00 |
| Backtest Novavax | | | Novavax History | | | Novavax Valuation | Previous |
Novavax Trading Date Momentum on November 14, 2023
| On October 03 2023 Novavax was traded for 6.97 at the closing time. The top price for the day was 6.97 and the lowest listed price was 6.97 . There was no trading activity during the period 0.0. Lack of trading volume on October 3, 2023 did not cause price change. The trading delta at closing time against the current closing price is 1.72% . |
Novavax Fundamentals Correlations and Trends
By evaluating Novavax's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novavax's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novavax financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novavax Stock history
Novavax investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novavax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novavax will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novavax stock prices may prove useful in developing a viable investing in Novavax
| Last Reported | Projected for 2023 | ||
| Weighted Average Shares | 78.2 M | 84.4 M | |
| Weighted Average Shares Diluted | 78.2 M | 84.4 M | |
| Issuance Purchase of Equity Shares | 248.6 M | 262 M |
Novavax Quarterly Market Capitalization |
|
Novavax Stock Technical Analysis
Novavax technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Novavax Period Price Range
Low | October 3, 2023 | High |
7.09 | 6.97 |
| -0.12 | -1.69% |
Novavax October 3, 2023 Market Strength
Market strength indicators help investors to evaluate how Novavax stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novavax shares will generate the highest return on investment. By undertsting and applying Novavax stock market strength indicators, traders can identify Novavax entry and exit signals to maximize returns
Novavax Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novavax stock's direction in advance. Along with the technical and fundamental analysis of Novavax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novavax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0168 | |||
| Jensen Alpha | 0.1814 | |||
| Total Risk Alpha | 0.6535 | |||
| Sortino Ratio | 0.0285 | |||
| Treynor Ratio | 0.0355 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide. Note that the Novavax information on this page should be used as a complementary analysis to other Novavax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Novavax Stock analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fund Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETF Directory Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Novavax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novavax. If investors know Novavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novavax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.11) | Revenue Per Share 19.149 | Quarterly Revenue Growth 1.283 | Return On Assets (0.18) | Return On Equity (8.98) |
The market value of Novavax is measured differently than its book value, which is the value of Novavax that is recorded on the company's balance sheet. Investors also form their own opinion of Novavax's value that differs from its market value or its book value, called intrinsic value, which is Novavax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novavax's market value can be influenced by many factors that don't directly affect Novavax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novavax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novavax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novavax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.